Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.62M Buy
30,110
+4,543
+18% +$524K 0.1% 162
2025
Q4
$2.69M Buy
25,567
+8,627
+51% +$810K 0.09% 179
2025
Q3
$1.42M Buy
16,940
+8,855
+110% +$729K 0.07% 208
2025
Q2
$640K Buy
8,085
+871
+12% +$69.2K 0.04% 305
2025
Q1
$647K Sell
7,214
-129
-2% -$12K 0.07% 239
2024
Q4
$730K Buy
7,343
+195
+3% +$20.1K 0.09% 189
2024
Q3
$812K Buy
7,148
+1,013
+17% +$120K 0.16% 127
2024
Q2
$760K Buy
6,135
+3,285
+115% +$423K 0.25% 96
2024
Q1
$376K Buy
+2,850
New +$351K 0.22% 129

Other funds holding MRK

Savvy Advisors Inc's MRK Position: Q1 2026 in Review

Savvy Advisors Inc increased its Merck (MRK) stake by 18% in Q1 2026, buying an estimated $524K and bringing the position to 30,110 shares worth $3.62M. The position accounts for 0.1% of the portfolio, ranked #162.

Savvy Advisors Inc first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Savvy Advisors Inc held 30,110 shares of Merck worth $3.62M as of Q1 2026.
  • Savvy Advisors Inc bought 4,543 Merck shares in Q1 2026, an estimated $524K.
  • Merck made up 0.1% of Savvy Advisors Inc's portfolio in Q1 2026, its #162 holding.
  • Savvy Advisors Inc first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Savvy Advisors Inc's 13F filing for Q1 2026, filed 11 May 2026.